| 1 | [SID103170845] | Active | EC50 | 0.0057 | 5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum [AID6142, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | EC50 | 0.0057 [uM] | | BioAssay | 5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum | | AID | 6142 | | BioAssay type | Literature | | Target | | | PubMed | 9046352 | | Data Table |  |
|
| 2 | [SID103170845] | Active | Ki | 0.027 | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells [AID65133, Type: Literature] | D(3) dopamine receptor [gi:1169206] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.027 [uM] | | BioAssay | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells | | AID | 65133 | | BioAssay type | Literature | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | 14521403 | | Data Table |  |
|
| 3 | [SID103170845] | Active | Ki | 0.027 | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells [AID65133, Type: Literature] | D(3) dopamine receptor [gi:1169206] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.027 [uM] | | BioAssay | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells | | AID | 65133 | | BioAssay type | Literature | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | 14521403 | | Data Table |  |
|
| 4 | [SID103170845] | Active | Ki | 0.027 | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells [AID65133, Type: Literature] | D(3) dopamine receptor [gi:1169206] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.027 [uM] | | BioAssay | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells | | AID | 65133 | | BioAssay type | Literature | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | 14521403 | | Data Table |  |
|
| 5 | [SID103170845] | Active | Ki | 0.027 | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells [AID65133, Type: Literature] | D(3) dopamine receptor [gi:1169206] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.027 [uM] | | BioAssay | Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells | | AID | 65133 | | BioAssay type | Literature | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | 14521403 | | Data Table |  |
|
| 6 | [SID103170845] | Active | Kd | 0.05012 | Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart [AID6028, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Kd | 0.05012 [uM] | | BioAssay | Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart | | AID | 6028 | | BioAssay type | Literature | | Target | | | PubMed | 2342053 | | Data Table |  |
|
| 7 | [SID103170845] | Active | Kd | 0.05012 | Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN) [AID6034, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Kd | 0.05012 [uM] | | BioAssay | Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN) | | AID | 6034 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID103170845] | Active | IC50 | 0.0613 | Concentration of compound required to inhibit the binding of radioligand [3H](R)-7-OH-DPAT to Dopamine receptor D3 in rat striatum [AID65470, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.0613 [uM] | | BioAssay | Concentration of compound required to inhibit the binding of radioligand [3H](R)-7-OH-DPAT to Dopamine receptor D3 in rat striatum | | AID | 65470 | | BioAssay type | Literature | | Target | | | PubMed | 12593651 | | Data Table |  |
|
| 9 | [SID103170845] | Active | Kd | 0.07943 | Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH) [AID6033, Type: other] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Kd | 0.07943 [uM] | | BioAssay | Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH) | | AID | 6033 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID103170845] | Active | Ki | 0.08 | Compound was evaluated for the binding affinity at Dopamine receptor D2 [AID62332, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.08 [uM] | | BioAssay | Compound was evaluated for the binding affinity at Dopamine receptor D2 | | AID | 62332 | | BioAssay type | Literature | | Target | | | PubMed | 7608898 | | Data Table |  |
|
| 11 | [SID103170845] | Active | Ki | 0.104 | Compound was evaluated for binding affinity towards DA D-2 receptor using radioligand [3H]SPI [AID65260, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.104 [uM] | | BioAssay | Compound was evaluated for binding affinity towards DA D-2 receptor using radioligand [3H]SPI | | AID | 65260 | | BioAssay type | Literature | | Target | | | PubMed | 1535660 | | Data Table |  |
|
| 12 | [SID103170845] | Active | Ki | 0.113 | Binding affinity to dopamine receptor D2 [AID65098, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.113 [uM] | | BioAssay | Binding affinity to dopamine receptor D2 | | AID | 65098 | | BioAssay type | Literature | | Target | | | PubMed | 1573641 | | Data Table |  |
|
| 13 | [SID103170845] | Active | IC50 | 0.127 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.127 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 14 | [SID103170845] | Active | IC50 | 0.127 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.127 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 15 | [SID103170845] | Active | IC50 | 0.127 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.127 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 16 | [SID103170845] | Active | IC50 | 0.127 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.127 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 17 | [SID103170845] | Active | IC50 | 0.127 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.127 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 18 | [SID103170845] | Active | IC50 | 0.2 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 19 | [SID103170845] | Active | IC50 | 0.2 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 20 | [SID103170845] | Active | IC50 | 0.2 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 21 | [SID103170845] | Active | IC50 | 0.2 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 22 | [SID103170845] | Active | Ki | 0.2 | Compound was evaluated for the binding affinity at 5- HT3 receptor subtype [AID6006, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.2 [uM] | | BioAssay | Compound was evaluated for the binding affinity at 5- HT3 receptor subtype | | AID | 6006 | | BioAssay type | Literature | | Target | | | PubMed | 7608898 | | Data Table |  |
|
| 23 | [SID103170845] | Active | Ki | 0.21 | Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor [AID6133, Type: Literature] | 5-hydroxytryptamine receptor 3A [gi:1168223] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.21 [uM] | | BioAssay | Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor | | AID | 6133 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 3A [gi:1168223] | | PubMed | 12593651 | | Data Table |  |
|
| 24 | [SID103170845] | Active | IC50 | 0.228 | Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane [AID6066, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.228 [uM] | | BioAssay | Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane | | AID | 6066 | | BioAssay type | Literature | | Target | | | PubMed | 12593651 | | Data Table |  |
|
| 25 | [SID103170845] | Active | Ki | 0.24 | Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor [AID5903, Type: Literature] | 5-hydroxytryptamine receptor 3A [gi:1168223] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.24 [uM] | | BioAssay | Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor | | AID | 5903 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 3A [gi:1168223] | | PubMed | 1573641 | | Data Table |  |
|
| 26 | [SID103170845] | Active | Ki | 0.285 | Binding affinity against Dopamine receptor D2 using [3H]spiperone as radioligand in rat striatum [AID65106, Type: other] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.285 [uM] | | BioAssay | Binding affinity against Dopamine receptor D2 using [3H]spiperone as radioligand in rat striatum | | AID | 65106 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID103170845] | Active | Ki | 0.303 | Affinity towards Dopamine receptor D2 in rat striatum using [3H]spiperone as radioligand [AID64938, Type: Literature] | D(2) dopamine receptor [gi:47117674] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.303 [uM] | | BioAssay | Affinity towards Dopamine receptor D2 in rat striatum using [3H]spiperone as radioligand | | AID | 64938 | | BioAssay type | Literature | | Target | D(2) dopamine receptor [gi:47117674] | | PubMed | 12593651 | | Data Table |  |
|
| 28 | [SID103170845] | Active | Ki | 0.348 | Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex [AID5891, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.348 [uM] | | BioAssay | Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex | | AID | 5891 | | BioAssay type | Literature | | Target | | | PubMed | 9464362 | | Data Table |  |
|
| 29 | [SID103170845] | Active | Ki | 0.443 | Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex [AID5876, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.443 [uM] | | BioAssay | Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex | | AID | 5876 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID103170845] | Active | Ki | 0.443 | Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex [AID5875, Type: other] | 5-hydroxytryptamine receptor 3A [gi:1168223] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.443 [uM] | | BioAssay | Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex | | AID | 5875 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 3A [gi:1168223] | | PubMed | | | Data Table |  |
|
| 31 | [SID103170845] | Active | IC50 | 0.444 | Concentration of compound required to inhibit the binding of radioligand [3H]spiperone to Dopamine receptor D2 in rat brain synaptic membrane [AID64274, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.444 [uM] | | BioAssay | Concentration of compound required to inhibit the binding of radioligand [3H]spiperone to Dopamine receptor D2 in rat brain synaptic membrane | | AID | 64274 | | BioAssay type | Literature | | Target | | | PubMed | 12593651 | | Data Table |  |
|
| 32 | [SID103170845] | Active | IC50 | 0.48 | Binding affinity against dopamine D2 receptor in rat brain synaptic membrane using [3H]-spiperone as radioligand [AID61325, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.48 [uM] | | BioAssay | Binding affinity against dopamine D2 receptor in rat brain synaptic membrane using [3H]-spiperone as radioligand | | AID | 61325 | | BioAssay type | Literature | | Target | | | PubMed | 9871571 | | Data Table |  |
|
| 33 | [SID103170845] | Active | IC50 | 0.48 | Inhibition of [3H]- spiperone binding to rat brain Dopamine receptor D2 [AID61539, Type: Literature] | D(2) dopamine receptor [gi:47117674] |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.48 [uM] | | BioAssay | Inhibition of [3H]- spiperone binding to rat brain Dopamine receptor D2 | | AID | 61539 | | BioAssay type | Literature | | Target | D(2) dopamine receptor [gi:47117674] | | PubMed | 9873388 | | Data Table |  |
|
| 34 | [SID103170845] | Active | Ki | 0.49 | Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement. [AID5888, Type: other] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.49 [uM] | | BioAssay | Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement. | | AID | 5888 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID103170845] | Active | Ki | 0.502 | Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand [AID5898, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.502 [uM] | | BioAssay | Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand | | AID | 5898 | | BioAssay type | Literature | | Target | | | PubMed | 2258903 | | Data Table |  |
|
| 36 | [SID103170845] | Active | Ki | 0.546 | Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor [AID6174, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.546 [uM] | | BioAssay | Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor | | AID | 6174 | | BioAssay type | Literature | | Target | | | PubMed | 12593651 | | Data Table |  |
|
| 37 | [SID103170845] | Active | IC50 | 0.565 | In vitro antagonistic activity against Dopamine receptor D2 was evaluated for the inhibition of [3H]spiperone binding [AID64290, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.565 [uM] | | BioAssay | In vitro antagonistic activity against Dopamine receptor D2 was evaluated for the inhibition of [3H]spiperone binding | | AID | 64290 | | BioAssay type | Literature | | Target | | | PubMed | 3397992 | | Data Table |  |
|
| 38 | [SID103170845] | Active | IC50 | 0.63 | Inhibitory activity against dopamine receptor D2 by 3H ligand binding experiments. [AID64457, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.63 [uM] | | BioAssay | Inhibitory activity against dopamine receptor D2 by 3H ligand binding experiments. | | AID | 64457 | | BioAssay type | Literature | | Target | | | PubMed | 1995885 | | Data Table |  |
|
| 39 | [SID103170845] | Active | IC50 | 0.63 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.63 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 40 | [SID103170845] | Active | IC50 | 0.63 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.63 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 41 | [SID103170845] | Active | IC50 | 0.63 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.63 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 42 | [SID103170845] | Active | IC50 | 0.708 | DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan) [AID625272, Type: other] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.708 [uM] | | BioAssay | DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan) | | AID | 625272 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID103170845] | Active | IC50 | 0.8 | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) [AID625249, Type: other] | Cytochrome P450 2D6 [gi:84028191] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.8 [uM] | | BioAssay | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | | AID | 625249 | | BioAssay type | other | | Target | Cytochrome P450 2D6 [gi:84028191] | | PubMed | | | Data Table |  |
|
| 44 | [SID103170845] | Active | IC50 | 0.8 | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) [AID625249, Type: other] | Cytochrome P450 2D6 [gi:84028191] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.8 [uM] | | BioAssay | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | | AID | 625249 | | BioAssay type | other | | Target | Cytochrome P450 2D6 [gi:84028191] | | PubMed | | | Data Table |  |
|
| 45 | [SID103170845] | Active | IC50 | 0.82 | Inhibitory concentration required for displacing radioligand [3H]SPI from DA D-2 receptor [AID64596, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.82 [uM] | | BioAssay | Inhibitory concentration required for displacing radioligand [3H]SPI from DA D-2 receptor | | AID | 64596 | | BioAssay type | Literature | | Target | | | PubMed | 1535660 | | Data Table |  |
|
| 46 | [SID103170845] | Active | IC50 | 0.88 | Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand [AID6063, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.88 [uM] | | BioAssay | Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand | | AID | 6063 | | BioAssay type | Literature | | Target | | | PubMed | 9871571 | | Data Table |  |
|
| 47 | [SID103170845] | Active | IC50 | 0.88 | Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor [AID6059, Type: Literature] | 5-hydroxytryptamine receptor 3A [gi:1168223] |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.88 [uM] | | BioAssay | Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor | | AID | 6059 | | BioAssay type | Literature | | Target | 5-hydroxytryptamine receptor 3A [gi:1168223] | | PubMed | 9873388 | | Data Table |  |
|
| 48 | [SID103170845] | Active | Ki | 0.9 | Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement. [AID6243, Type: other] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.9 [uM] | | BioAssay | Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement. | | AID | 6243 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID103170845] | Active | IC50 | 0.912 | Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum [AID6164, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | IC50 | 0.912 [uM] | | BioAssay | Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum | | AID | 6164 | | BioAssay type | Literature | | Target | | | PubMed | 12593651 | | Data Table |  |
|
| 50 | [SID103170845] | Active | Ki | 0.974 | Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum [AID6241, Type: other] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103170845 | | CID | 4168 | | Outcome | Active | | Ki | 0.974 [uM] | | BioAssay | Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum | | AID | 6241 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|